Status:
COMPLETED
Study With a Topical Gel to Treat Common Warts in Adults
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Conditions:
Warts
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The primary purpose of this study is to evaluate the effectiveness in adults of 2 different strengths of resiquimod gel applied to common wart(s) five times a week for up to 12 weeks. A second purpos...
Eligibility Criteria
Inclusion
- Diagnosis of common warts
- Two forms of birth control
Exclusion
- Pregnant or breast feeding
- Other types of warts, ie. plantar
- Currently participating in another clinical study
- Chronic viral hepatitis B or C
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00117871
Start Date
October 1 2004
Last Update
February 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minnesota Clinical Study Center
Fridley, Minnesota, United States, 55432